Lilly Consultants dismiss significance of suicide risk while Lilly will issue Black Box warning label for Strattera Mon, 10 Oct 2005 On September 29, the FDA issued the public health advisory alerting health care professionals that children and adolescents taking Strattera prescribed for ADHD should be closely monitored for changes…
Efforts to Expand Emergency Exception from Informed Consent Thu, 6 Oct 2005 The following announcement posted to the IRB Forum by Dr. Robert Nelson, a KOL (key opinion leader) within the close-knit IRB community– who serve as gatekeepers of human research –demosntrates that the culture of secrecy is entrenched in…
20% Drop in Psych Drugs Prescribed for US Children – WashPost Sat, 8 Oct 2005 The Washington Post reports (below) that prescriptions for antidepressants for children have dropped an unprecedented 20% in the US. A continuing series of substantiated reports and Black Box warnings about an increased risk of suicide,…
NY Banker–“Perfect Gentleman” shot son and fatally shot himself – prescribed antidepressant found Thu, 6 Oct 2005 Yet another example of a person prescribed an SSRI antidepressant–in this case Lexapro–who explodes in an uncharacteristic murderous rampage. The NY Daily News reports: A “perfect gentleman” banker who had threatened his family…
Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…
ADHD drug – Cylert withdrawn from market due to Liver Toxicity, a Major Risk of Psychotropic Drugs Tue, October 25, 2005 The FDA announced that another drug prescribed for ADHD–Cylert–was removed from the US market for safety reasons. On September 25, 2005, the Associated Press reported: “Eli Lilly said it…
A Taxpayer-Funded Clinical Trial Registry Exists! Thu, 6 Oct 2005 A former FDA medical officer reports: A Taxpayer-Funded Clinical Trials Registry and Results Database: It already exists within the US Food and Drug Administration. But the agency keeps the vital information about drug safety secret and inaccessible. So, all the…
Jayson Blair, reporter fired from NY Times, helped PhRMA scare consumers . . . Sun, 23 Oct 2005 Below Peter Rost, V-P of Marketing at Pfizer who has turned whistleblower on the pharmaceutical industry sent us the most amazing example of this industry’s loathsome underhanded tactics aimed at scaring the…
Ethics / Science of ARDS Controversy Continues – J Medical Ethics-BMJ Thu, 6 Oct 2005 The ethics and science of a controversial clinical trial sponsored by the US government and conducted at multiple sites by the ARDS Network comprising of prestigious academic medical centers is the subject of a continuing…
FDA May Require Longer Studies Before Approving Psych Drugs – WSJ Tue, 18 Oct 2005 The Wall Street Journal reports that the FDA has sent out feelers to drug manufacturers to provide “longer-term efficacy data” for psychotropic drugs. This comes after a mountain of evidence shows placebo “works” just as…
SAMHSA Backs Away From TeenScreen & TMAP Mon, 24 Oct 2005 On October 17, a meeting took place with Charles Currie in Washington DC – with some in attendance by conference call. Currie is the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), the federal agency charged…
Is Tamiflu worth it? Thu, 27 Oct 2005 Many knowledgable experts in pharmacology have expressed dismay over the hysteria mounting for Tamiflu, a drug that has shown to be only marginally effective at best in reducing ther number of days one experinces flu symptoms. In elderly patients who are at…
